A cobalt-containing acidic amino acid complex and its use for treating cancer
US-2024398829-A1 · Dec 5, 2024 · US
US12370161B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12370161-B2 |
| Application number | US-202217668678-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 10, 2022 |
| Priority date | Nov 24, 2017 |
| Publication date | Jul 29, 2025 |
| Grant date | Jul 29, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure relates to a composition for preventing, alleviating or treating pruritus and/or atopy using an N-acetylamino acid or an N-acylamino acid having almost no side effects on the human body. Also, the present disclosure relates to a cosmetic composition for moisturizing skin or soothing skin. The composition of the present disclosure may be utilized to ameliorate a problematic skin condition caused by various causes, or to safely and effectively alleviate or treat pruritus and/or atopy without concern about side effects.
Opening claim text (preview).
The invention claimed is: 1. A method for decreasing expression of IL-4 and interferon γ in skin tissue in treatment of atopic dermatitis, comprising the steps of: a) identifying a subject having atopic dermatitis; and b) administering a composition to the subject, wherein said composition comprises N-acetyltryptophan or a pharmaceutically acceptable salt thereof as an active ingredient. 2. The method according to claim 1 , wherein the N-acetyltryptophan is N-acetyl-L-tryptophan. 3. The method according to claim 1 , wherein the composition is prepared into a formulation selected from the group consisting of a formulation for external application to skin, an aerosol, a spray, a collyrium, an oral medication, and an injection. 4. The method according to claim 1 , wherein the N-acetyltryptophan consists of N-acetyl-L-tryptophan. 5. The method according to claim 1 , wherein the composition further comprises a surfactant, a sterilizer, an antioxidant, a UV absorber, an anti-inflammatory agent or a cooling agent.
Preparations for dry skin · CPC title
Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin · CPC title
having five membered rings, e.g. pyrrolidone carboxylic acid · CPC title
substituted by amido group(s) · CPC title
Face masks · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.